 |
|
aminothiadiazole
A synthetic derivative of nicotinamide adenine dinucleotide (NAD). Aminothiadiazole competitively inhibits inosine 5-monophosphate dehydrogenase, thereby disrupting the regulation of cell proliferation and differentiation in a number of cells. This agent is also a selective human adenosine A3 receptor antagonist. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 2-Aminothiadiazole
Amino 134-Thiadiazole | | | | Abbreviations: | | A-TD
ATDA | | | | Code name: | | FDA 0084 | | | | Chemical structure names: | | - 1,3, 4-Thiadiazol-2-amine (9CI)
- 1,3, 4-Thiadiazole, 2-Amino- (8CI)
- 1,3,4-Thiadiazole, 2-Amino
- 2-Amino-1,3,4-thiadiazole
- 2-Amino-1-thia-3,4-diazole
| | |
| Previous: | aminobenzoate potassium, aminocamptothecin, aminolevulinic acid, aminopeptidase inhibitor CHR-2797, aminopterin | | Next: | amiodarone hydrochloride, AML mRNA plus lysate loaded autologous dendritic cell vaccine, Ammoidin, ammonium tetrathiomolybdate, ammonium trichlorotellurate |
|
|
